SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050245
Filing Date
2017-08-08
Accepted
2017-08-08 16:02:21
Documents
43
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13346_110q.htm 10-Q 710168
2 EX-31.1 a17-13346_1ex31d1.htm EX-31.1 11077
3 EX-32.1 a17-13346_1ex32d1.htm EX-32.1 5386
  Complete submission text file 0001104659-17-050245.txt   3283292

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT espr-20170630.xml EX-101.INS 696363
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20170630.xsd EX-101.SCH 22206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20170630_cal.xml EX-101.CAL 34771
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20170630_lab.xml EX-101.LAB 281585
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20170630_pre.xml EX-101.PRE 183000
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20170630_def.xml EX-101.DEF 94828
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 171014647
SIC: 2834 Pharmaceutical Preparations